Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06001788
Title Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Kura Oncology, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Banner MD Anderson Cancer Center RECRUITING Gilbert Arizona 85234 United States Details
UCLA Health - Bowyer Oncology Center RECRUITING Los Angeles California 90095 United States Details
UCI Health Chao Family Comprehensive Cancer Center RECRUITING Orange California 92868 United States Details
Smilow Cancer Hospital at Yale New Haven RECRUITING New Haven Connecticut 06511 United States Details
The University of Kansas RECRUITING Kansas City Kansas 66160 United States Details
Karmanos Cancer Institute RECRUITING Detroit Michigan 48201 United States Details
Henry Ford Cancer Institute RECRUITING Detroit Michigan 48202 United States Details
University of Nebraska Medical Center RECRUITING Omaha Nebraska 68198 United States Details
Memorial Sloan Kettering Cancer Center RECRUITING New York New York 10021 United States Details
Stony Brook Cancer Center RECRUITING Stony Brook New York 11794 United States Details
Atrium Health Levine Cancer Center RECRUITING Charlotte North Carolina 60201 United States Details
OU Health Stephenson Cancer Center RECRUITING Oklahoma City Oklahoma 73104 United States Details
Prisma Health RECRUITING Greenville South Carolina 29615 United States Details
MD Anderson Cancer Center RECRUITING Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field